F. A. Blostein, B. Bose, A. Hill, K. Actkins, A. M. Lake, N. Freilich, P. Straub, M. Niarchou, B. E. Stranger, L. K. Davis
Sex differences exist in complex diseases, but the genetic architecture of sex differences in quantitative clinical traits is understudied. Here, we performed sex-stratified genome-wide association studies of 508 clinical traits from electronic health records (EHRs) in 64,956 European-ancestry individuals in the Vanderbilt biobank, BioVU, with replication in the UK Biobank and Colorado Center for Personalized Medicine biobank. Most trait distributions differed significantly by sex. We identified a female-specific locus for erythrocyte distribution width at PIEZO1 and sex-differentiated effect magnitudes at APOE (LDL cholesterol) and SLC2A9 (uric acid) that replicated across biobanks, varied with age, and partially mediated associations with heart disease and gout. Opposite-direction sex effects were less replicable. Ascertainment bias could be addressed using inverse-probability weighting. Sex-stratified colocalization with eQTLs nominated additional candidate genes. Differential effect magnitude, not opposing effects, predominate in sex-specific genetic architecture, requiring large sample sizes for discovery that can be achieved using EHR data.